These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2867066)

  • 1. Oxypertine in tardive dyskinesia.
    Youssef HA
    Ir Med J; 1985 Nov; 78(11):340. PubMed ID: 2867066
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxypertine in tardive dyskinesia.
    O'Shea B; Falvey J
    Ir Med J; 1985 Jul; 78(7):202-3. PubMed ID: 2863234
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
    Ogawa T; Nagao T; Kashiwabara K; Fujiwara Y; Harada T; Otsuki S
    Clin Ther; 1984; 7 Spec No():1-17. PubMed ID: 6085032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxypertine for tardive dyskinesia.
    Freeman H; Soni SD
    Br J Psychiatry; 1980 May; 136():522-3. PubMed ID: 6104524
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of tardive dyskinesia with oxypertine--preliminary clinical experience and a brief review of the literature.
    Kazamatsuri H
    Compr Psychiatry; 1980; 21(5):352-7. PubMed ID: 6106539
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled trial of oxypertine in tardive dyskinesia.
    Freeman HL; Soni SD; Carpenter L
    Int Pharmacopsychiatry; 1980; 15(5):281-91. PubMed ID: 6114934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
    Akiyama K; Nagao T; Yamamoto M; Fujimoto A; Ebara T; Sato M; Otsuki S
    Folia Psychiatr Neurol Jpn; 1983; 37(2):129-35. PubMed ID: 6200411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxypertine in tardive dyskinesia: a long-term controlled study.
    Soni SD; Freeman HL; Bamrah JS; Sampath G
    Acta Psychiatr Scand; 1986 Nov; 74(5):446-50. PubMed ID: 2880458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicentre clinical trial of oxypertine in anxiety neurosis.
    Mungavin JM
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:47-54. PubMed ID: 4585548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of a new psychopharmaceutical agent, oxypertine, in anxiety states].
    Martínez Salazar F
    Prensa Med Mex; 1973; 38(9):354-61. PubMed ID: 4793354
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial of oxypertine in patients with anxiety.
    Forrest AD; Maule M
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:30-3. PubMed ID: 4585547
    [No Abstract]   [Full Text] [Related]  

  • 15. Is oxypertine an activating tranquillizer?
    Merskey H; Buhrich N
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:26-9. PubMed ID: 4668282
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clozapine in severe tardive dyskinesia: a case report.
    Meltzer HY; Luchins DJ
    J Clin Psychopharmacol; 1984 Oct; 4(5):286-7. PubMed ID: 6149239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative trial of oxypertine and chlorpromazine in the treatment of acute psychoses.
    Wadzisz FJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):784-92. PubMed ID: 4984044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.